MYGN
NASDAQStockMyriad Genetics, Inc.
$4.67-0.18 (-3.71%)
52-Week Range
$3.84
$10.12
Key Stats
Market Cap
436.7M
P/E Ratio
—
Dividend Yield
—
Beta
1.93
Volume
1.4M
Avg Volume
2.1M
Performance
1M
+7.06%
3M
-30.62%
6M
-33.65%
YTD
-21.01%
1Y
-51.84%
3Y
-79.57%
5Y
-84.34%
Price Chart
ETF Exposure
MYGN is held by 141 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| GNOG.L | Global X - Genomics & Biotechnology UCITS ETF | 0.41% |
| GNOM.L | Global X - Genomics & Biotechnology UCITS ETF | 0.41% |
| GNOM | Global X - Genomics & Biotechnology ETF | 0.34% |
| QQQS | Invesco NASDAQ Future Gen 200 ETF | 0.32% |
| HAPS | Harbor Human Capital Factor US Small Cap ETF (HAPS) | 0.31% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 0.29% |
| DMRS | DeltaShares S&P 600 Managed Risk ETF | 0.28% |
| SAGP | Strategas Global Policy Opportunities ETF | 0.26% |
| SLY | SPDR S&P 600 Small Cap ETF | 0.18% |
| CURE.AX | Global X - S&P Biotech ETF | 0.16% |
| ISMD | Inspire Small/Mid Cap ETF | 0.16% |
| XBI | State Street SPDR S&P Biotech ETF | 0.15% |
| PQSV | PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Value ETF | 0.13% |
| NUSC | Nuveen ESG Small-Cap | 0.11% |
| VFQY | Vanguard U.S. Quality Factor ETF | 0.10% |
| FSML | Franklin Small Cap Enhanced ETF | 0.09% |
| VVL.TO | Vanguard Global Value Factor ETF | 0.08% |
| VFMF | Vanguard U.S. Multifactor ETF | 0.08% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.08% |
| VVLU.AX | Vanguard Global Value Equity Active ETF | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.06% |
| FESM | FIDELITY ENHANCED SMALL CAP ETF | 0.06% |
| DRDR.L | iShares Healthcare Innovation UCITS ETF | 0.05% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.05% |
| ESIX | State Street SPDR S&P SmallCap 600 ESG ETF | 0.05% |
| FLQS | Franklin U.S. Small Cap Multifactor Index ETF | 0.05% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.04% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.04% |
| USML.L | Invesco S&P SmallCap 600 UCITS ETF | 0.04% |
| VFVA | Vanguard U.S. Value Factor ETF | 0.04% |
| IBB | iShares Biotechnology ETF | 0.04% |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 0.04% |
| IJS | iShares S&P Small-Cap 600 Value ETF | 0.04% |
| PWS | Pacer WealthShield ETF | 0.04% |
| SLYV | State Street SPDR S&P 600 Small Cap Value ETF | 0.04% |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.04% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.03% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.03% |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.03% |
| IWN | iShares Russell 2000 Value ETF | 0.03% |
| IJR | iShares Core S&P Small-Cap ETF | 0.03% |
| IJR.AX | iShares S&P Small-Cap ETF | 0.03% |
| XSMC.TO | iShares S&P U.S. Small-Cap Index ETF | 0.03% |
| XSMH.TO | iShares S&P U.S. Small-Cap Index ETF (CAD-Hedged) | 0.03% |
| IDP6.L | iShares S&P SmallCap 600 UCITS ETF | 0.03% |
| IUS3.DE | iShares S&P SmallCap 600 UCITS ETF | 0.03% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.03% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.03% |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.03% |
| FNDA | Schwab Fundamental U.S. Small Company Index ETF | 0.03% |
Page 1 of 3Next
About MYGN ETF Exposure
Myriad Genetics, Inc. (MYGN) is held by 141 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 436.7M, MYGN is a widely held institutional stock. The stock currently trades at $4.67. Investors can gain exposure to MYGN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold MYGN, sorted by portfolio weight.